Nov 14, 2017 02:33 am UTC| Business
YAVNE, Israel, Nov. 13, 2017 -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn and wound management, today announced...
Nov 14, 2017 02:30 am UTC| Business
LOS ANGELES, Nov. 13, 2017 -- Air Lease Corporation (NYSE:AL) (the “Company”) announced the pricing on November 13, 2017 of its public offering of $600 million aggregate principal amount of 2.750% unsecured senior notes...
Vertical Farming Market to Reach $6,372.5 Million by 2023: P&S Market Research
Nov 14, 2017 02:30 am UTC| Business
NEW YORK, Nov. 14, 2017 -- According to PS Market Research, global vertical farming market is expected to reach $6,372.5 million by 2023, witnessing CAGR of 24.2% on account of increasing awareness levels among...
Nov 14, 2017 02:05 am UTC| Business
NEW YORK, Nov. 13, 2017 -- Pomerantz LLP announces that a class action lawsuit has been filed against SCANA Corporation (“SCANA” or the “Company”) (NYSE: SCG) and certain of its officers. The class action, filed in...
PDL Community Bancorp Announces 2017 Third Quarter Results
Nov 14, 2017 02:00 am UTC| Business
NEW YORK, Nov. 13, 2017 -- PDL Community Bancorp, (the “Company”) (NASDAQ:PDLB), the holding company for Ponce Bank (the “Bank”), reported a net loss of $3.2 million for the quarter ended September 30, 2017 compared to...
LINN Energy Announces Third Quarter 2017 Earnings Conference Call
Nov 14, 2017 01:12 am UTC| Business
HOUSTON, Nov. 13, 2017 -- LINN Energy, Inc. (OTCQB:LNGG) will host a conference call Tuesday, November 14, 2017 at 11 a.m. (Central) to discuss the company’s third quarter 2017 results. There will be prepared remarks by...
Nov 14, 2017 01:00 am UTC| Business
PORTLAND, Ore. and CAMBRIDGE, Mass., Nov. 13, 2017 -- MolecularMD announces that it has now become a Preferred Provider of Promega’s Microsatellite Instability (MSI) v1.2 Analysis System. MolecularMD has completed...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update